Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) CEO Thomas J. Shaw purchased 21,142 shares of the stock in a transaction on Wednesday, October 23rd. The stock was acquired at an average price of $0.74 per share, with a total value of $15,645.08. Following the completion of the acquisition, the chief executive officer now directly owns 14,794,794 shares of the company’s stock, valued at approximately $10,948,147.56. This represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Retractable Technologies Stock Down 2.7 %
Shares of RVP stock traded down $0.02 during trading hours on Thursday, hitting $0.72. 79,461 shares of the company were exchanged, compared to its average volume of 88,255. Retractable Technologies, Inc. has a 52 week low of $0.71 and a 52 week high of $1.34. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01. The business has a 50 day moving average of $0.85 and a two-hundred day moving average of $1.00.
Retractable Technologies (NYSE:RVP – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The company had revenue of $6.03 million during the quarter.
Institutional Investors Weigh In On Retractable Technologies
Analyst Ratings Changes
Separately, StockNews.com started coverage on Retractable Technologies in a research report on Friday, October 18th. They issued a “hold” rating for the company.
View Our Latest Analysis on RVP
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.
Recommended Stories
- Five stocks we like better than Retractable Technologies
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is the Nasdaq? Complete Overview with History
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.